Silo Pharma Inc.
SILO | NASDAQ
$1.23
-$0.02 (-1.60%)
At close: Oct 30, 2026, 4:00 PM ET
$1.23
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Market Data
Market Cap $1.39M
Enterprise Value $-4.04M
Beta 0.75
Average Volume 166.35K
Shares Outstanding (Diluted) 1.1M
Shares Change YoY 162.4%
Institutional Ownership 0.02%
Exchange NASDAQ
ISIN US82711P3001
Price Performance
Price Change 1M -18.5%
Price Change 3M -70.6%
Price Change 6M -82.0%
Price Change YTD -75.9%
Price Change 1Y -84.8%
Price Change 3Y -94.6%
Price Change 5Y -99.2%
1M CAGR (ann.) -33.1%
1Y CAGR (ann.) -84.8%
5Y CAGR (ann.) -61.1%
All-Time CAGR -60.3%
Valuation
PE Ratio -0.23
Forward PE N/A
PEG Ratio -0.00
Forward PEG -0.08
PS Ratio 25.67
Forward PS 19.30
PB Ratio 0.28
P/FCF Ratio -0.42
P/Adj. FCF Ratio -0.40
P/OCF Ratio -0.40
EV/Sales -74.79
EV/EBIT 0.88
EV/EBITDA 0.88
EV/FCF 1.21
Earnings Yield -435.0%
FCF Yield -240.6%
Adj. FCF Yield -250.6%
Financial Health
Net Cash $5.43M
Total Debt $0
Cash & Short-Term Investments $5.43M
Total Assets $5.95M
Current Ratio 5.36
Quick Ratio 5.36
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.00
OCF / Debt N/A
Interest Coverage -112.03
Altman Z-Score -5.99
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin -474.3%
Operating Profit Margin -8250.5%
EBITDA Margin -8473.3%
Net Profit Margin -8269.5%
FCF Margin -6176.8%
Adj. FCF Margin -6433.4%
SBC / Revenue 256.6%
SBC Impact (per share) -4.2%
Returns
Return on Assets -75.1%
Return on Equity -81.7%
Return on Invested Capital -91.3%
Return on Capital Employed -91.3%
Return on Tangible Assets -77.9%
Historical Growth (CAGR)
Revenue CAGR 3Y -9.1%
Revenue CAGR 5Y -6.0%
Revenue CAGR 10Y -15.0%
EPS CAGR 3Y 48.5%
EPS CAGR 5Y -68.7%
EPS CAGR 10Y -0.2%
FCF CAGR 3Y 2.6%
FCF CAGR 5Y -8.4%
FCF CAGR 10Y -27.0%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Dec 2, 2026
EPS Estimate (next Q) -$4.80
EPS Growth Est (next Q) 3900.0%
Revenue Est (next Q) $18K
Revenue Growth Est (next Q) -0.1%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $0.00
Price Target Upside N/A
Cash Flow
Operating Cash Flow $-3.34M
Free Cash Flow $-3.34M
Adj. Free Cash Flow $-3.48M
FCF Per Share -$3.04
OCF Per Share -$3.04
OCF/S Ratio -6176.8%
Income Statement
Revenue $54.08K
Gross Profit $-256.5K
Operating Income $-4.46M
EBITDA $-4.58M
Net Income $-4.47M
EPS (Diluted) -$5.35
Revenue / Employee $18.03K
Profit / Employee $-1.49M
Employees 3
Add to Watchlist
Select watchlists to add or remove SILO